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E2F transcriptional regulators control human-
cell proliferation by repressing and activating
the transcription of genes required for cell-cycle
progression, particularly the S phase. E2F pro-
teins repress transcription in association with
retinoblastoma pocket proteins, but less is
known about how they activate transcription.
Here, we show that the humanG1 phase regula-
tor HCF-1 associates with both activator (E2F1
and E2F3a) and repressor (E2F4) E2F proteins,
properties that are conserved in insect cells. Hu-
man HCF-1-E2F interactions are versatile: their
associations and binding to E2F-responsive
promoters are cell-cycle selective, and HCF-1
displays coactivator properties when bound to
the E2F1 activator and corepressor properties
when bound to the E2F4 repressor. During the
G1-to-S phase transition, HCF-1 recruits the
mixed-lineage leukemia (MLL) and Set-1 his-
tone H3 lysine 4 methyltransferases to E2F-
responsivepromoters and induceshistonemeth-
ylation and transcriptional activation. These
results suggest that HCF-1 induces cell-cycle-
specific transcriptional activation by E2F pro-
teins to promote cell proliferation.
INTRODUCTION
A central aspect of development and disease is the control
of cell proliferation through regulation of the cell cycle. A
key step in this regulation is the control of the passage
from the G1 to S phases of the cycle. This critical passage
is tightly coupled to the transcriptional control of genes in-
volved in growth and DNA replication. In mammalian cells,
this temporal control of gene expression is performed pri-
marily by the E2F family of transcription factors (reviewedMby Trimarchi and Lees [2002], Blais and Dynlacht [2004],
and Dimova and Dyson [2005]).
E2F transcription factors, originally discovered as acti-
vators of adenovirus transcription, are heterodimeric tran-
scription factors that consist of one member from the E2F
protein family, called E2F1–E2F8, and another member
from the DP protein family, called DP1 and DP2. Of the E2F
proteins, E2F1–E2F5 represent a subfamily that shares the
property of binding one or more members of the retino-
blastoma (Rb) ‘‘pocket’’ protein family pRb, p107, and
p130. The activation or repression specificity of E2F fac-
tors is largely conferred by the E2F protein subunit. Among
the E2F1–E2F5 proteins, E2F1, E2F2, and E2F3a primarily
activate transcription (‘‘activator E2Fs’’), and E2F3b, E2F4,
and E2F5 primarily repress transcription (‘‘repressor
E2Fs’’).
The transcriptional activity of E2F transcription factors
is modulated by multiple mechanisms. In quiescent or
early G1 cells, repressor E2Fs bind p107 or p130 and in-
hibit transcription (reviewed by Dyson [1998] and Harbour
and Dean [2000]). As cells progress through the G1 phase,
activator E2Fs replace the repressor E2Fs on promoters
but repression continues via association of activator E2Fs
with the pRb pocket protein, which recruits the Sin3 his-
tone deacetylase (HDAC), Su(Var) 39 histone methyltrans-
ferase, and SWI/SNF chromatin remodeler to promoters.
Eventually, the activator E2Fs are freed of the repressive
pRb complexes by cyclin-CDK-induced pRb phosphory-
lation (Dyson, 1998), allowing activation of transcription
of genes required for S phase. Thus, E2F factors are im-
portant positive and negative regulators of the cell cycle.
Although some E2F coactivators are known (e.g., histone
acetyltransferases [HATs]; Hsu et al., 2001; Lang et al.,
2001; Louie et al., 2004; El Messaoudi et al., 2006), the
molecular details of how E2Fs effect passage into the S
phase are relatively poorly understood. Here, we describe
that the human G1 phase regulator HCF-1 is a key player
in E2F-mediated transcriptional activation.
Human HCF-1, for herpes simplex virus (HSV) host cell
factor-1, is an important regulator of multiple phases of the
cell cycle. It is conserved in animals and associates witholecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inc. 107
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HCF-1 Is an E2F Family Coregulatora variety of histone-modifying activities, including the tri-
thorax-related mixed-lineage leukemia (MLL) and Set1
histone H3 lysine 4 methyltransferases (H3K4 HMTs),
Sin3 HDAC, and MOF HAT (Wysocka et al., 2003; Yo-
koyama et al., 2004; Dou et al., 2005; Smith et al., 2005).
Native HCF-1 is a heterodimeric complex of N- and C-
terminal HCF-1N and HCF-1C subunits resulting from pro-
teolytic maturation of a single precursor protein (Wilson
et al., 1993, 1995; Kristie et al., 1995). The HCF-1N subunit
is responsible for promoting G1 phase progression, and
the HCF-1C subunit is involved in proper M phase progres-
sion (Goto et al., 1997; Julien and Herr, 2003). A molecular
understanding of how HCF-1 supports cell-cycle progres-
sion is lacking, although in HSV-infected cells HCF-1 is
known to stabilize a multiprotein-DNA transcriptional reg-
ulatory complex with the virion protein VP16 that activates
the HSV immediate-early promoters (see Gerster and
Roeder [1988]; reviewed in Wysocka and Herr [2003]).
Although HCF-1 is not known to bind DNA directly, each
subunit displays chromatin association activity (Wysocka
et al., 2001; Julien and Herr, 2004). For example, an N-
terminal HCF-1N ‘‘Kelch’’ domain can tether HCF-1 to chro-
matin by binding the tetrapeptidemotif D/EHxY (where x de-
notes any residue), called the HCF-1-binding motif (HBM;
Freiman and Herr, 1997; Lu et al., 1998), present in some
DNA-binding proteins (see Luciano and Wilson [2003]).
The biological importance of HCF-1N-chromatin associa-
tion through the Kelch domain is emphasized by the finding
that a single point mutation in this domain (called P134S)
prevents HBM binding and causes both a temperature-
induced G1 phase cell-proliferation arrest and disruption
of HCF-1 chromatin association in the temperature-sensi-
tive baby hamster kidney cell line tsBN67 (Goto et al.,
1997; Wysocka et al., 2001). Interestingly, inactivation of
the pRb pocket-protein family can overcome the HCF-
1P134S-induced G1 phase arrest without restoring HCF-1
chromatin association, a result that has suggested that
HCF-1 regulates G1 phase progression by opposing the
function of one or more pocket proteins (Reilly et al., 2002).
A number of the aforementioned properties of HCF-1
make it an attractive candidate to be an E2F coregulator:
the E2F1 and E2F4 proteins carry the HBM sequence re-
sponsible for mediating HCF-1 association (Luciano and
Wilson, 2003; Knez et al., 2006; this study); pocket-protein
inactivation can overcome the tsBN67 HCF-1P134S-in-
duced G1 phase arrest; and HCF-1 binds histone-modify-
ing activities associated with activation of transcription
(e.g., MLL family of H3K4 HMTs). Our present studies in-
dicate that HCF-1 has multiple roles as a coregulator of
E2F functions and show that it plays a direct role in the ac-
tivation of E2F-responsive promoters through the cell-
cycle-specific recruitmentof the MLL familyof H3K4 HMTs.
RESULTS
HeLa Cell E2F Protein Association with HCF-1
To initiate our study of E2F protein-HCF-1 association, we
(1) prepared HeLa cell nuclear extracts, (2) immunoprecip-108 Molecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Initated HCF-1, and (3) probed the immunoprecipitates for
E2F1, E2F2, E2F3 (a or b), and E2F4 proteins by immuno-
blot analysis. As shown in Figure 1A, E2F1, E2F3, and
E2F4 proteins, but not E2F2, were recovered in the HCF-
1, but not mock, immunoprecipitates (compare lanes 1–3),
indicating that HCF-1 associates with multiple members
of the E2F protein family. Related to these observations,
Knez et al. (2006) have previously observed native HeLa
cell E2F4-HCF-1 association as well as the association
of ectopically overexpressed E2F1 and HCF-1 molecules
in hamster cells. HCF-1 association with both activator
and repressor E2Fs suggests that HCF-1 is involved in
E2F-mediated transcriptional activation and repression.
HCF-1 Associates with Activator and Repressor
E2Fs at Different Stages of the Cell Cycle
Although HCF-1 is required for cell-cycle progression
(Goto et al., 1997), its levels and nuclear localization are
not known to be cell-cycle regulated (see Figure S1Ba in
Figure 1. HCF-1 Associates with E2F Proteins
(A) Native HCF-1 association with endogenous HeLa cell E2F proteins.
A nuclear extract was immunoprecipitated with anti-HCF-1 (lane 3) or
nonimmune (lane 2) sera, and recovered E2F proteins were visualized
by immunoblot with anti-E2F1, E2F2, E2F3, and E2F4 antisera. NE
(lane 1), 30 mg HeLa cell nuclear extract (3% input).
(B) HCF-1 associates with activator and repressor E2Fs differentially
during the cell cycle. Synchronized HeLa cell nuclear extracts (see
the Supplemental Data) were immunoprecipitated with anti-HCF-1
(lanes 3 and 6) and nonimmune (lanes 2 and 5) sera and analyzed by
immunoblot with anti-E2F1 (lanes 1–3) and E2F4 (lanes 4–6) antisera.
NE (lanes 1 and 4), 30 mg HeLa cell nuclear extract (3% input).c.
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HCF-1 Is an E2F Family CoregulatorFigure 2. Conserved HBMs in E2F Transcription Factors
(A) Schematic structure of human HCF-1 and Drosophila dHCF. Struc-
tural elements are labeled above HCF-1, and related elements are
shown similarly for dHCF. HCF-1PRO, HCF-1 proteolytic processing re-
peats; HCF-1Fn3, fibronectin type 3 repeats; NLS, nuclear localization
signal. The position of the HCF-1 tsBN67 P134S mutation is indicated.
(B) Schematic structure of human activator E2F1–E2F3a and repressor
E2F4 proteins. Functional elements are indicated. CBM, cyclin binding
motif; LZ, leucine zipper; MB, marked box; NES, nuclear export signal;
NLS, nuclear localization signal. Black and gray arrowheads, positions
of perfect and imperfect HCF-1-binding motifs (HBM), respectively.
Dashed line in E2F3 indicates E2F3b N terminus.
(C) Conserved E2F1 HBM sequences. (Top) sequence alignment of
E2F1 HBM region from human (NP_005216), mouse (AAL90789),
chicken (NP_990550), zebrafish (XP_696201), and Drosophila
(NP_524437) E2F1. CBM (orange) and HBM (blue) sequences are indi-
cated. Dots indicate identity with the human sequence. // denotes
missing Drosophila dE2F1 amino acids 53–99. (Bottom) sequenceMothe Supplemental Data available with this article online),
suggesting that HCF-1 regulates the cell cycle through
temporally regulated association with effector proteins.
Thus, we asked whether nuclear HCF-1 association with
the activator E2F1 and repressor E2F4 differs during the
cell cycle. We synchronized cells in G1/S by double thymi-
dine block treatment and isolated cells at additional cell-
cycle stages by differential timed release in normal media.
Given our interest in G1 and S phase progression, we used
cell populations synchronized for the early G1 (G1E), late
G1 (G1L), G1/S, and S phases (Figure S1).
As shown in Figure 1B, consistent with a G1-to-S ex-
pression pattern, E2F1 increased from the G1E to the G1/
S fractions and then decreased from the S to G1E fractions
(lane 1; see also Figure S1B). Nonetheless, HCF-1 associ-
ation with E2F1 was delayed toward the G1/S and S phase
fractions (compare lanes 1 and 3). In contrast, as expected
(Lindeman et al., 1997), nuclear E2F4 protein was present
throughout the cell cycle (lane 4) but only bound HCF-1 pri-
marily in the G1E and S phase fractions (compare lanes
4 and 6). Thus, HCF-1 interacts with activator E2F1 and
repressor E2F4 molecules during respective cell-cycle
phases in which these E2F molecules regulate the cell cy-
cle (e.g., E2F1 at G1/S and E2F4 at G1E), suggesting an
active role for HCF-1 in cell-cycle control by E2F proteins.
Some E2F Proteins Possess Conserved HBMs
and HBM-like Sequences
The HCF and E2F proteins used in this study are shown
schematically in Figure 2. Figure 2A illustrates human
and Drosophila melanogaster HCF proteins, highlighting
the conserved regions. Although Drosophila HCF (dHCF)
lacks the HCF-1PRO repeats responsible for HCF-1 pro-
teolytic cleavage (Kristie et al., 1995; Wilson et al., 1995),
through an unknown process it also undergoes proteolytic
maturation into dHCFN and dHCFC subunits (Mahajan
et al., 2003; Guelman et al., 2006).
Figure 2B illustrates E2F1–E2F4, with HBMs indicated
by arrowheads. Note that E2F3a and E2F3b differ in the
N-terminal region—here we only used the E2F3a ‘‘activa-
tor’’ form. Consistent with their HCF-1 association, E2F1
and E2F4 have HBMs but in distinctly different positions:
in E2F1, it lies in the N-terminal region adjacent to the cy-
clin A binding motif (CBM) RxL (Krek et al., 1994; Xu et al.,
1994; Lowe et al., 2002), and in E2F4 it overlaps the pocket
protein-binding site near the C terminus (see Lee et al.
[2002]). Interestingly, the E2F1 (Figure 2C) and E2F4 (Fig-
ure 2D) HBMs are highly conserved in vertebrates and
even insects (e.g., Drosophila).
alignment of human E2F1, E2F2 (NP_004082), and E2F3a
(NP_001940) proteins.  indicates absence of the corresponding
amino acid.
(D) Conserved E2F4 HBM sequence. Sequence alignment of HBM
(blue) and pRb-binding site (red, Lee et al., 2002) from human
(NP_001941), mouse (NP_683754), chicken (CAG32002), and zebra-
fish (AAH56832) E2F4, and Drosophila dE2F2 (NP_477355). dE2F2
has nonoverlapping HBM and pRb-binding sites. // denotes missing
dE2F2 amino acids 298–347.lecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inc. 109
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tein, although very similar to E2F1, does not possess an
HBM (Figure 2C, bottom). To our surprise, although E2F3a
and/or E2F3b associates with HCF-1, neither has a canon-
ical HBM. Instead, they have a degenerate albeit con-
served (data not shown) HBM-like sequence (GHQY, var-
iant position underlined) at a position corresponding with
that of the E2F1 HBM (Figure 2C, bottom).
The HCF-1 Kelch Domain Interacts with E2F3a and
E2F4, but Not E2F2, in a Yeast Two-Hybrid Assay
To dissect HCF-1-E2F interactions, we used the yeast
two-hybrid assay. The human HCF-1 Kelch domain was
fused to the GAL4 DNA-binding domain (DBD) as ‘‘bait.’’
Full-length E2F1–E2F4 sequences were fused to the GAL4
transcriptional activation domain (AD) as ‘‘prey.’’ Two-
hybrid specificity controls showed that each individual
bait and prey molecule did not sustain histidine-indepen-
dent yeast growth (Figure S2a), but all four E2F-prey pro-
teins were expressed as they scored positive with a DP1
bait protein (Bandara et al., 1993) as shown in Figure 3Aa.
Consistent with the HeLa cell association results (Fig-
ure 1A), E2F3a and E2F4 scored positive and E2F2 scored
negative for HCF-1 Kelch-domain interaction in the two-
hybrid assay (Figure 3Ab). And consistent with a biologi-
cally relevant Kelch-domain interaction, the tsBN67 P134S
Kelch-domain mutation (Figure 3Ac) and the E2F3a
G142A and E2F4 D389A HBM mutations (Figure 3Ad)
interfered with the interaction. The HCF-1 Kelch-domain
interaction with E2F4 is consistent with that described
by Knez et al. (2006); in contrast, the yeast two-hybrid as-
say did not detect any significant E2F4 interaction with the
HCF-1 Basic region (Figure S2b). The unexpected result
with E2F3a, in which a divergent HBM appears to direct
E2F3a association with the Kelch domain, suggests that
E2F3 proteins possess an atypical albeit functional HBM.
Evidence for an E2F1 Autoinhibitory
Association with HCF-1
Although E2F1 associated with HCF-1 in HeLa cells (Fig-
ure 1A), the full-length HBM-containing E2F1 protein did
not interact with the HCF-1 Kelch domain in the two-
hybrid assay (Figure 3Ab), even though it interacts with
DP1 (Figure 3Aa) and contained no point mutations (data
not shown). In contrast, a 153 amino-acid C-terminal E2F1
deletion activated HBM-dependent HCF-1 Kelch domain
interaction (compare E2F1[1–284] with the HBM mutant
E2F1[1–284, D97A]) (Figure 3Ba) that is sensitive to the
P134S Kelch-domain mutation (Figure 3Bb). This result
suggested that full-length E2F1 contains inhibitory se-
quences that prevent HBM recognition. Indeed, a series of
E2F1 N- and C-terminal truncations, with even one as
small as seven amino acids (E2F1[1–430]), interacted with
the HCF-1 Kelch domain as long as they retained the HBM
(Figure 3B, bottom). The unexpected inactivity of the full-
length E2F1 prey construct was verified by showing that
a de novo full-length E2F1 prey construct from two active
N- and C-terminal truncations (E2F1[94–437] and E2F1110 Molecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier In[1–402]) was inactive (Figure 3B, construct 1–281 + 282–
437). We conclude that full-length E2F1 has regions that
can inhibit its own interaction with the HCF-1 Kelch domain.
This proposed autoinhibition depends on the nature of
the E2F1 HBM, because when the E2F1 HBM and sur-
rounding sequence are replaced with the corresponding
prototypical VP16 HBM sequence (LETDHQYLAE to
VMREHAYSRA, HBM underlined), the resulting full-length
E2F1VP16HBM molecule interacts with the HCF-1 Kelch
domain (Figure 3Bc). Together with the observed E2F1-
HCF-1 association in HeLa cells, these two-hybrid results
suggest that E2F1 has a latent ability to associate with
HCF-1.
HCF-1-E2F Interactions Have Been Conserved
during Evolution
As the HCF-1 Kelch domain and the E2F1 and E2F4 HBMs
are conserved in Drosophila (see Figure 2), we tested
whether there is an HCF-1-E2F interaction in insect cells.
Indeed, dHCF is recovered in endogenous dE2F1 and
dE2F2 (the ortholog of human E2F4) immunoprecipitates
of aDrosophilaSL2extract (Figure 3C). (Recovery of dE2F1
and dE2F2 in dHCF immunoprecipitates is shown in Fig-
ure S3.) Furthermore, dE2F1 and dE2F2 interact with
both the dHCF and human HCF-1 Kelch domains and hu-
man E2F1(1–284) interacts with the dHCF Kelch domain
in the two-hybrid assay (Figure 3D). These cross-species
interactions suggest that HCF-1 Kelch domain-E2F HBM
interactions have been highly conserved; in contrast, the
human E2F1 autoinhibition has not been conserved in
Drosophila.
Selective Association of Ash2-Containing
H3K4 HMTs and Sin3 HDAC with HCF-1-E2F1
and HCF-1-E2F4 Complexes
As aforementioned, HCF-1 associates with chromatin-
modifying activities associated with both activation (e.g.,
MLL and Set1 H3K4 HMTs) and repression (i.e., Sin3
HDAC) of transcription (Wysocka et al., 2003; Yokoyama
et al., 2004; Dou et al., 2005). The activator MLL and
Set1 H3K4 HMTs are protein complexes that each pos-
sess three shared subunits, Ash2, WDR5, and RBP5,
and a unique SET-domain catalytic subunit. Interestingly,
HCF-1 can associate with the ‘‘activator’’ Set1 H3K4 HMT
complex and ‘‘repressor’’ Sin3 HDAC complex simulta-
neously, but, when bound to the viral transcriptional acti-
vator VP16, HCF-1 associates with the Set1 H3K4 HMT
but not the Sin3 HDAC, suggesting preferential associa-
tion of an activator with HCF-1 complexes containing
activating histone-modifying activities (Wysocka et al.,
2003). The finding here that HCF-1 can bind to cellular
transcriptional regulators associated with either activation
(i.e., E2F1) or repression (i.e., E2F4) led us to ask whether
HCF-1-E2F1 and HCF-1-E2F4 complexes might display
selective association with the HMT or HDAC activities in
HeLa cells.
To answer this question, we used an HeLa cell line ex-
pressing a Flag-epitope-tagged HCF-1N subunit (calledc.
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HCF-1 Is an E2F Family CoregulatorFigure 3. HCF-1 Interacts with E2F1,
E2F3, and E2F4, but Not E2F2
(A) E2F-HCF-1 yeast two-hybrid assay. Yeast
strain PJ69 cotransformed with GAL4-DBD
bait and GAL4-AD prey fusion expression plas-
mids, as indicated, was assayed for growth
with and without histidine (see Experimental
Procedures).
(B) Mutant E2F1-HCF-1 yeast two-hybrid as-
say. (Top) assay as in (A). E2F1VP16HBM, re-
placement of E2F1 HBM by VP16 HBM (see
text). (Bottom) interaction of N- and C-terminal
E2F1 deletion mutants with the HCF-1 Kelch
domain. Positive (+) or negative (–) interaction
is indicated. The position of the HBM is indi-
cated (:). The full-length E2F1(1–281 + 282–
437) construct (shown by the differentially
dotted line) was created by replacing the
pGADGH-E2F1(94–437) BamHI-BglII fragment
with that from pGADGH-E2F1(1–402).
(C)Drosophila dE2F-dHCF association. An SL2
nuclear extract was immunoprecipitated with
anti-dE2F1 (lane 3), anti-dE2F2 (lane 4), or non-
immune (lane 2) sera, and recovered dHCF
was analyzed by immunoblot with rabbit anti-
dHCF antibody. NE (lane 1), 30 mg SL2 nuclear
extract (5% input).
(D) Drosophila dE2F-dHCF (Da) and human
andDrosophila E2F-HCF (Db) yeast two-hybrid
assay. Assay as in (A). – indicates empty GAL4-
DBD or GAL4-AD vectors.Molecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inc. 111
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HCF-1 Is an E2F Family Coregulatorf-HCF-1N; Wysocka et al., 2001) and performed the dou-
ble immunoprecipitation protocol outlined in Figure 4A—
first isolating f-HCF-1N complexes and subsequently
f-HCF-1N-containing E2F1 or E2F4 complexes—followed
by immunoblot analysis for coimmunoprecipitating com-
ponents. To maximize HCF-1-E2F1 and HCF-1-E2F4
complex isolation (see Figure 1B) and focus our attention
on where E2F1 and E2F4 are active, we employed nuclear
extracts from the G1/S phase for HCF-1-E2F1 analysis
and the G1E phase for HCF-1-E2F4 analysis.
As expected, the G1/S f-HCF-1N/E2F1 and G1E f-HCF-
1N/E2F4 immunoprecipitates both contained f-HCF-1N,
and E2F1 and E2F4, respectively (Figures 4Ba and 4Bb,
compare lanes 2 and 3, and 5 and 6). To reveal coassoci-
ated MLL family H3K4 HMTs as a whole, we probed for the
Figure 4. Selective Association of Ash2-Containing H3K4
HMT and Sin3 HDAC with HCF-1-E2F1 and HCF-1-E2F4
Complexes
(A) Schematic diagram showing double-immunoprecipitation proce-
dure to isolate f-HCF-1N-E2F complexes. f-HCF-1N, Flag-epitope
tagged HCF-1N subunit.
(B) f-HCF-1N-E2F1 (lanes 2 and 3) and f-HCF-1N-E2F4 (lanes 5 and 6)
immunoprecipitates from f-HCF-1N (lanes 3 and 6) and normal (lanes 2
and 5) HeLa cell G1/S (lanes 2 and 3) and G1E (lanes 5 and 6) phase
extracts were analyzed by immunoblot with anti-E2F1 ([Ba], lanes
1–3), E2F4 ([Ba], lanes 4–6), Flag for f-HCF-1N (Bb), Sin3A and Ash2
(Bc), pRb ([Bd], lanes 1–3), and p130 ([Bd], lanes 4–6) antisera. NE,
HeLa cell nuclear extract from G1/S (lane 1) and G1E (lane 4) phases
corresponding to 0.5% (Ba–Bc) or 0.17% (Bd) of input.112 Molecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inshared Ash2 subunit, and, to reveal coassociated Sin3
HDAC, we simultaneously probed for the Sin3A subunit
(Figure 4Bc). Compared to one another, the HCF-1-E2F1
complexes bound the Ash2 polypeptide preferentially
and the HCF-1-E2F4 complexes bound the Sin3A poly-
peptide preferentially (compare lanes 3 and 6). These dif-
ferences were not reflected in the general levels of Ash2 or
Sin3A association with HCF-1 in G1E and G1/S fractions
(Figure S4), indicating that the differences in HCF-1-E2F1
and HCF-1-E2F4 complexes are specific to these different
complexes. These results suggest that, as a coregulator,
HCF-1 is able to selectively associate with activating
activities (e.g., one or more MLL family H3K4 HMTs) with
E2F1 in the G1/S phase and repressive activities (e.g.,
Sin3 HDAC) with E2F4 in the G1E phase.
pRb Can Associate with HCF-1-E2F1 Complexes
in the G1/S Fraction, but p130 Fails to Associate
with HCF-1-E2F4 Complexes in the G1E Fraction
As aforementioned, owing to the positions of the HBM (see
Figures 2B–2D), HCF-1 and pocket-protein association
with E2F4, but not E2F1, is likely to be mutually exclusive.
Thus, we determined whether the G0/G1 pocket protein
p130 is present in the G1E HCF-1-E2F4 complexes and
pRb in the G1/S HCF-1-E2F1 complexes. Consistent
with an interference between pocket-protein and HCF-1
interaction with E2F4, no p130 was detected in the isolated
G1E HCF-1-E2F4 complexes (Figure 4Bd, lane 6) even
though p130 associates with HCF-1-free E2F4 in these ex-
tracts (data not shown). Interestingly, however, pRb was
detected in the G1/S HCF-1-E2F1 complexes (Figure 4Bd,
lane 3), indicating that HCF-1 and pRb can bind simulta-
neously to E2F1. The electrophoretic mobility of the
HCF-1-E2F1-associated pRb was phosphatase sensitive
(data not shown). We conclude that at some point(s) in
the G1-to-S phase transition of the HeLa cell cycle, phos-
phorylated pRb and HCF-1 are bound together to E2F1,
perhaps a transition state between a repressive E2F1 com-
plex and activating E2F1 complex. Consistent with it being
a G1-to-S phase transition state, the levels of pRb asso-
ciated with the HCF-1-E2F1 complex are significantly
reduced in S phase cells (Figure S5).
HCF-1 Binds to E2F-Responsive Promoters
in a Cell-Cycle-Regulated Manner
To extend the biological significance of the HCF-1-E2F
protein association, we asked whether HCF-1 associates
with E2F-responsive promoters by chromatin immunopre-
cipitation (ChIP) as shown in Figure 5A. For this analysis,
we selected three E2F-regulated promoters previously
analyzed in detail by ChIP—p107, E2F1, and cyclin A
(Takahashi et al., 2000; a fourth promoter cdc25 was also
analyzed and gave analogous results, data not shown)—
and a negative control from the U2 snRNA gene, called
U2C (N. Hernandez, personal communication). Consistent
with previous studies (Takahashi et al., 2000; Wells et al.,
2000), in asynchronous HeLa cells, E2F1 and E2F4 pro-
teins were detected on all three promoters, but not onc.
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HCF-1 Is an E2F Family CoregulatorFigure 5. Cell-Cycle-Regulated HCF-1 and MLL/Set1 H3K4 HMT Association with E2F-Responsive Promoters
(A) HCF-1 binds to E2F-responsive promoters. PCR products of ChIP analyses of asynchronous HeLa cells with nonimmune (lane 2), HCF-1N (lane 3),
E2F1 (lane 4), and E2F4 (lane 5) antisera are shown. Input (lane 1) corresponds to 0.3% of ChIP input.
(B) Cell-cycle regulation of HCF-1 association with E2F-responsive promoters. Quantitation of E2F1, E2F2, and HCF-1N ChIP analyses of G1E (green),
G1L (yellow), G1/S (red), and S (blue) phase-synchronized HeLa cells by triplicate real-time PCR of the indicated promoters is shown.
(C) Cell-cycle regulation of MLL family H3K4 HMT association with and H3K4 methylation status of E2F-responsive promoters. Quantitation of MLLC,
Set1, WDR5, and H3K4 di- and trimethylation ChIP analyses of synchronized HeLa cells as in (B). MLLN antiserum generated results analogous to
MLLC (data not shown). All ChIP experiments in (B) and (C) were performed at least three and usually six times with similar results; the results shown
in (B) and (C) are from a single representative experiment. Data are represented as mean ± SD. The relatively high levels of p107 signal seen for MLLC
in the G1L phase were not reproduced in other experiments.the U2C region (Figure 5A, lanes 4 and 5). HCF-1 was also
detected on these three promoters, but not the U2C region
(lane 3; note that although negative in the ChIP results
shown here, U2C was positive for histone H3 ChIP,
Figure S6). Thus, during at least some point of the cellMocycle, HCF-1 is likely present on these E2F-responsive
promoters.
Because HCF-1 interacts with E2F1 and E2F4 at differ-
ent stages of the cell cycle, we reasoned that HCF-1
might occupy these E2F-responsive promoters in alecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inc. 113
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ChIP analysis with HeLa cells synchronized as in
Figure 1B. Consistent with differential association of
E2F1 and E2F4 with E2F-responsive promoters through
the cell cycle, E2F1 bound the three promoters more prev-
alently in the G1/S and S phase fractions and E2F4 bound
more prevalently in the S and early G1E fractions
(Figure 5B). (We note that the cell-cycle phase-specific
E2F1 promoter occupancy we observe is delayed com-
pared to Takahashi et al. [2000], which could result from
the different cells [HeLa versus T98G] or cell-synchroniza-
tion strategies [thymidine block versus serum starvation]
used.) Interestingly, HCF-1 displayed an E2F-responsive
promoter occupancy that resembles the sum of the E2F1
and E2F4 protein-promoter occupancy, precisely the
phases during which E2F1- or E2F4-HCF-1 association
is observed (Figure 1B). These results suggest HCF-1
involvement in both E2F1 and E2F4 transcriptional regula-
tion of E2F-responsive promoters.
Cell-Cycle-Specific Recruitment of MLL and Set1
H3K4 HMT Complexes to E2F-Responsive
Promoters
The selective association of Ash2 with HCF-1-E2F1 pro-
tein complexes (Figure 4) prompted us to ask whether
MLL H3K4 HMT family members occupy the E2F-respon-
sive promoters in a cell-cycle phase-specific manner. We
therefore performed ChIP analysis for the MLL and Set1
H3K4 HMT catalytic subunits and their shared WDR5 sub-
unit (Figure 5C). Remarkably, all three proteins showed
similar cell-cycle-dependent promoter binding patterns
to E2F1, consistent with the preferential association of
H3K4 HMT complexes with E2F1 as opposed to E2F4
(Figure 4). These results suggest that E2F1 recruits H3K4
HMT activities to E2F-responsive promoters around the
transition from the G1 to S phases.
Because H3K4 HMTs methylate H3K4, we tested for di-
and trimethylation of H3K4 at these promoters (Figure 5C).
H3K4 dimethylation was relatively constant in the four
samples. In contrast, the H3K4 trimethylation was en-
riched in the G1/S and S samples coinciding with E2F1
and H3K4 HMT occupancy, suggesting that trimethylation
more closely tracks the transcriptional activation status of
these promoters than does dimethylation.
HCF-1 Recruits MLL and Set1 H3K4 HMTComplexes
to E2F-Responsive Promoters and Participates
in E2F-Responsive Promoter Activation
The results in Figures 4 and 5 led us to hypothesize that
HCF-1 recruits H3K4 HMT complexes to E2F-responsive
promoters during the G1-to-S phase transition. If true,
HCF-1 depletion should lead to loss of H3K4 HMT recruit-
ment to E2F-responsive promoters at the G1-to-S phase
transition. We therefore performed siRNA knockdown of
HCF-1 in HeLa cells (Julien and Herr, 2003) and ChIP anal-
ysis of G1/S-synchronized HCF-1-depleted cells. To min-
imize long-term effects of loss of HCF-1, we analyzed cells
2 days after initial siRNA treatment, a time point at which114 Molecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier InHCF-1 is depleted but the cells have not stopped prolifer-
ating (Julien and Herr, 2004; see Figure S7A), thus permit-
ting G1/S phase cell isolation.
HCF-1 protein levels (Figure 6Ba) and hence E2F-
responsive promoter binding (Figure 6A) were successfully
knocked down by the 2 day siRNA treatment. In contrast,
E2F1 binding was largely unaffected (Figure 6A). Signifi-
cantly, however, there was a dramatic decrease in H3K4
HMT-component (i.e., MLL, Set1, and WDR5) occupancy
on these promoters (Figure 6A). In an independent repli-
cate experiment where the HCF-1 siRNA-induced deple-
tion was only about 50%, the decrease in MLL, Set1,
and WDR5 signal was correspondingly attenuated (see
Figures S7C and S7D). To show that the H3K4 HMT-com-
ponent decreases reflected promoter occupancy specifi-
cally and not just protein depletion, we probed for WDR5
in the HCF-1 siRNA-treated cells and did not detect any
change in its levels (Figure S7B). These results suggest
that HCF-1 serves as an intermediary to recruit MLL family
H3K4 HMT activities to E2F-responsive promoters. Con-
sistent with this conclusion, in contrast to minimal effects
on global H3K4 trimethylation by HCF-1 siRNA treatment
(Figure 6Bb), the E2F-responsive promoter H3K4 trime-
thylation levels were significantly reduced (Figure 6A).
These results suggest that during the transition from the
G1 to the S phase, HCF-1 directs the recruitment of MLL
family H3K4 HMT activity to E2F-responsive promoters,
which results in H3K4 trimethylation and transcriptional
activation. To test this hypothesis, we performed real
time RT-PCR analysis of p107, E2F1, and cyclin A tran-
scripts and compared their levels to those ofGAPDH tran-
scripts. Consistent with the requirement of HCF-1 for acti-
vation of these promoters, 72 hr HCF-1 siRNA treatment
leads to their inactivity (Figure 6C). Furthermore, in the
G1/S phase cells after 48 hr siRNA treatment where E2F1
is still bound, HCF-1 depletion leads to a marked reduction
in the levels of p107, E2F1, and cyclin A transcripts (Fig-
ure 6C). The continued presence of promoter-bound
E2F1 but loss of transcripts suggests that HCF-1 is an im-
portant effector of E2F1 transcriptional activation during
the G1-to-S phase. These results suggest that a major
element of how E2F1 brings about the activation of E2F-
responsive promoters is by recruiting HCF-1 and its asso-
ciated MLL family H3K4 HMT complexes to these
promoters.
DISCUSSION
Our studies have revealed mechanisms by which E2F cell-
proliferation transcription factors function through con-
served associations with the G1 phase regulator HCF-1.
Both activator and repressor E2F proteins associate with
HCF-1 and, depending on the E2F factor, HCF-1 associ-
ates with ‘‘activating’’ H3K4 HMT complexes (e.g., with the
activator E2F1) or with the ‘‘repressive’’ Sin3 HDAC com-
plex (e.g., with the repressor E2F4). These selective asso-
ciations are cell cycle dependent on E2F-responsive pro-
moters in concert with the expected activity of E2F1 andc.
Molecular Cell
HCF-1 Is an E2F Family CoregulatorFigure 6. HCF-1 Recruits MLL/Set1
H3K4 HMT Complexes to E2F-Respon-
sive Promoters and Participates in Their
Transcriptional Activation
(A) HCF-1 recruitment of MLL/Set1 H3K4 HMT
complexes. ChIP analyses of G1/S-synchro-
nized control (black) and HCF-1 (white)
siRNA-treated HeLa cells using the indicated
antisera. The signals for HCF-1 siRNA-treated
cells immunoprecipitated with the anti-HCF-1
antiserum are set to 1, with all other signals
indicated as relative-fold differences.
(B) HCF-1 and trimethylated H3K4 levels in
siRNA-treated cells. Immunoblot analysis of
HCF-1 (Ba), trimethylated H3K4 (Bb), and b-
actin (Bc) proteins from control (lane 1) and
HCF-1 (lane 2) siRNA-treated G1/S-synchro-
nized cells used in (A) is shown.
(C) HCF-1 depletion is accompanied by re-
duced expression of E2F-regulated genes. To-
tal RNA isolated from HCF-1 and control
siRNA-treated cells was amplified using real-
time RT-PCR for the indicated mRNAs. Signals
from 48 hr control siRNA-treated cells (black)
are set at 100% for each gene, and signals in
48 hr (gray) and 72 hr (white) HCF-1 siRNA-
treated cells are indicated as the percentage
of control. All p107, E2F1, and cyclin A signals
were normalized to the GAPDH mRNA signals
from the respective siRNA treatment. GAPDH
signals shown are not normalized. Data are
represented as mean ± SD.E2F4. Significantly, during G1-to-S phase progression,
HCF-1 recruits MLL family H3K4 HMT complexes to
E2F-responsive promoters and stimulates both H3K4
trimethylation at these promoters and the levels of the as-
sociated transcripts. We propose that HCF-1 promotes
passage from the G1 phase to the S phase of the cell cycle
by supporting transcriptional activation by E2F1.
A Diversity of E2F Factor-HCF-1
Molecular Interactions
This study has revealed diverse interactions between
E2F1–E2F4 and the HCF-1 Kelch domain. Thus, E2F4 dis-
plays direct interaction with HCF-1 through a canonical
HBM whereas E2F2, which lacks an HBM, does not asso-
ciate with HCF-1. In contrast, E2F1, while possessing a ca-
nonical HBM, inhibits its own association with HCF-1 via
a form of autoinhibition that is exquisitely sensitive to the
integrity of the E2F1 molecule: small deletions of E2F1
or changes to its HBM can activate E2F1 HBM association
with HCF-1 (Figure 3). This autoinhibition is overcome in
HeLa cells by an unknown mechanism. We suggest that
posttranslational modification (e.g., phosphorylation) is a
likely mechanism. Lastly, E2F3a associates with HCF-1Mwithout a canonical HBM, suggesting additional diversity
in HBM sequences.
There is also the diversity in the temporal association of
HCF-1 with the activator E2F1 and the repressor E2F4, re-
vealed by the association of HCF-1 with E2F1 in the G1/S
and S phase samples and with E2F4 in the S and G1E sam-
ples. And, in these different points of the cell cycle, HCF-1
is recruiting either (1) a ‘‘repressive’’ chromatin modifier—
the Sin3 HDAC—to E2F4 when E2F-responsive promoters
are repressed or (2) ‘‘activating’’ chromatin modifiers—the
MLL family of H3K4 HMTs—to E2F1 when E2F-responsive
promoters are active as illustrated in Figure 7A. Thus,
HCF-1 plays a directive role in the nature of transcriptional
regulatory complexes formed by sequence-specific tran-
scriptional regulators.
Multiple Mechanisms for Sin3 HDAC Promoter
Recruitment by E2F4
The repressor E2F4 associates with pocket proteins, in
particular p107 and p130, which themselves associate
with the Sin3 HDAC corepressor (Lai et al., 1999). Interest-
ingly, the E2F4 HBM overlaps the pocket protein-bind-
ing site (Figure 2) and p130 does not associate witholecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inc. 115
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protein and HCF-1 association with E2F4 is mutually exclu-
sive. Nevertheless, when HCF-1 is bound to E2F4, the Sin3
HDAC is also present. Thus, E2F4 may repress transcrip-
tion of E2F-responsive promoters by recruiting the Sin3
HDAC either through association with pocket proteins or
HCF-1. Interestingly, p107 or p130 is not present on about
75% of E2F4 target genes in early G1 phase (Balciunaite
et al., 2005) and Sin3 recruitment to some E2F-responsive
promoters is unaffected in p107–/–p130–/– MEFs (Rayman
et al., 2002). These results suggest that pocket proteins
are not the only proteins involved in E2F4-mediated
repression, and our results suggest that HCF-1 is an im-
portant player in recruiting Sin3 HDAC complexes to
E2F4-regulated promoters.
A Model for Cell-Cycle-Regulated Transcriptional
Activation by E2F1
Figure 7B presents a simple view of how we imagine that
E2F1 effects G1-to-S phase activation of E2F-responsive
promoters. It involves a transition from E2F1-bound pRb-
mediated repressive complexes to E2F1-bound HCF-1-
mediated MLL family H3K4 HMT complexes that lead
to H3K4 methylation and transcriptional activation. The
MLL family of H3K4 HMTs is a particularly attractive medi-
Figure 7. HCF-1, a Coregulator of E2F-Regulated Transcrip-
tion
(A) Model of HCF-1 as a coregulator of both E2F-mediated activation
and repression of transcription. The model proposes that HCF-1 selec-
tively associates with ‘‘activator’’ H3K4 HMT complexes, when bound
to E2F1, to activate transcription and with ‘‘repressor’’ Sin3 HDAC
complex, when bound to E2F4, to repress transcription.
(B) Model for E2F1-repressive to E2F1-activating complexes during
the G1-to-S phase transition. See text for details.116 Molecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inator of E2F transcriptional activation, because H3K4
trimethylation is known to directly recruit the NURF chro-
matin remodeler to support gene expression (Wysocka
et al., 2006).
Gene-Specific Recruitment of MLL
Our study provides insights into how MLL, the best stud-
ied of MLL family H3K4 HMTs (see Ruthenburg et al.
[2007]), is recruited to chromatin in a gene- and cell-cycle-
specific manner. Despite considerable progress in under-
standing the molecular function of MLL, largely precipi-
tated by its involvement in human leukemias (reviewed
by Hess [2004]), mechanisms of MLL recruitment to target
genes remain poorly understood. A conserved mecha-
nism of recruitment observed with both the yeast MLL
family homolog Set1/COMPASS (Shilatifard, 2006) and
human MLL is direct association with RNA polymerase II
and components of the basal machinery (Dou et al.,
2005; Milne et al., 2005a; Guenther et al., 2005). Mounting
evidence, however, suggests that in humans MLL plays
gene-specific regulatory roles through promoter-specific
recruitment (Milne et al., 2005b; Sierra et al., 2006; Dreijer-
ink et al., 2006). Our work provides a direct mechanism for
promoter-specific MLL recruitment for transcriptional ac-
tivation—HCF-1-mediated recruitment to E2F-responsive
promoters by E2F1. There may also be direct mechanisms
of E2F recruitment of MLL proteins to E2F-responsive pro-
moters because Takeda et al. (2006) have shown that MLL
and/or MLL2 can interact with E2F2–E2F6. Given that
HCF-1 associates with the MLL family of H3K4 HMTs in
multiple phases of the cell cycle (e.g., Figures S4 and
S5), we predict that HCF-1-mediated recruitment of the
MLL family of H3K4 HMTs to specific promoters will occur
in other regulatory pathways involving HCF-1-interacting
regulators.
Interestingly, MLL proteins are now implicated in both
promoting cell-cycle progression through activation of
E2F-dependent genes (Takeda et al., 2006; this study)
and in inhibiting cell-cycle progression through activation
of cyclin-dependent kinase inhibitor genes (Milne et al.,
2005b). Thus, MLL has a varied role in regulating cell
proliferation.
In Their Association with Activator E2Fs,
HCF-1 and pRb May Have Opposing Roles
Inactivation of pocket proteins by the SV40 large T antigen
and adenovirus E1A oncoprotein can rescue the tempera-
ture-sensitive HCF-1-induced G1 phase arrest of tsBN67
cells (Reilly et al., 2002). These observations have sug-
gested that HCF-1 opposes pocket-protein function, in
particular pRb. The results presented here indicate that
this opposition is quite direct as pRb and HCF-1 bind the
same molecule—E2F1—and indeed can bind simulta-
neously to E2F1 (Figure 4) in what we suggest is a transi-
tion complex from the repressive pRb-E2F1 to activating
HCF-1-E2F1 complexes.
Recent studies have suggested a two-step cyclin-CDK
phosphorylation-induced pRb and E2F1 dissociationc.
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domain of the E2F1-DP1 heterodimer and the classical
pRb-binding site are sequentially disrupted (Rubin et al.,
2005). Because pRb is already phosphorylated but still
associated with E2F1 in the pRb-E2F1-HCF-1 complex
(Figure 4), we propose that HCF-1 binds to an intermedi-
ate pRb-E2F1 complex in which pRb has undergone early
phosphorylation by cyclin D/CDK4; subsequent cyclin-
CDK phosphorylation events would then release the
HCF-1-E2F1 complex from pRb.
Although we show that HCF-1 and pRb both associate
with E2F1, this result per se does not explain why pocket-
protein inactivation by T antigen and E1A can overcome
the loss of HCF-1 association with E2F1 (Reilly et al.,
2002) as in this study HCF-1 is required for activation of
transcription by E2F1 (Figure 6). We suggest that HCF-
1-mediated recruitment of MLL family H3K4 HMTs is not
required for transcriptional activation when the pocket
proteins are inactivated because E2F complexes no lon-
ger mark promoters with repressive modifications (i.e.,
H3K9 methylation and deacetylation).
Differential Targeting of E2F-Associated Molecules
by DNA Viruses
The DNA tumor viruses (e.g., adenoviruses and papova
viruses) and HSV modulate the cell cycle of infected cells
but in opposite ways. The DNA tumor viruses induce S
phase entry to create an infected-cell environment sup-
portive of viral replication. In contrast, HSV, which en-
codes its own proteins for viral DNA replication, inhibits
infected-cell entry into the S phase (de Bruyn Kops and
Knipe, 1988). It is interesting, therefore, that the DNA tu-
mor viruses and HSV target apparently opposing coregu-
lators of E2F function. The DNA tumor viruses target the
E2F1-associated ‘‘repressor’’ pRb (e.g., with E1A, T anti-
gen, and E7), and HSV targets the E2F1-associated ‘‘acti-
vator’’ HCF-1 (i.e., with VP16). Indeed, HSV might inhibit
G1 phase progression, at least in part, through competi-
tive VP16 association with HCF-1, thus preventing its nor-
mal association with molecules such as E2F1. Whichever
the case, the studies described here illustrate how, like
DNA tumor viruses, HSV targets the heart of the cell-cycle
regulatory machinery through the interaction of VP16 with
the E2F-associated protein HCF-1.
EXPERIMENTAL PROCEDURES
Cell Culture
HeLa cells were grown in Dulbecco’s modified Eagles’s medium
(DMEM) with 10% fetal bovine serum (FBS). HeLa cells stably express-
ing N-terminally Flag-epitope-tagged HCF-1 residues 2–1011 (f-HCF-
1N) were described previously (Wysocka et al., 2001). Cells were
synchronized using double thymidine block as described (see the Sup-
plemental Data). Drosophila SL2 cells were cultured at 25C in
Schneider’s (GIBCO) media containing 10% heat-inactivated FBS.
Coimmunoprecipitation and Immunoblot Analysis
Nuclear extracts were prepared (Dignam et al., 1983) and coimmuno-
precipitations performed (Wysocka et al., 2003) as described. Se-
quential anti-Flag and either E2F1 or E2F4 immunoprecipitation ofMf-HCF-1N-containing complexes was performed as described (Wy-
socka et al., 2003). For immunoblot analysis, nitrocellulose mem-
branes were incubated for 1 hr with 10 ml of LI-COR blocking buffer,
then with relevant antibodies in 50% LI-COR blocking buffer and
50% PBST (PBS containing 0.2% Triton X-100) at 4C overnight.
The membranes were washed at least three times in PBST followed
by incubation with the appropriate secondary antibodies (Alexa Fluor
or IRE Dye) at 1:15,000 dilution in 50% LI-COR blocking buffer and
50% PBST at room temperature for 1 hr. The membranes were
washed at least three times in PBST and scanned with an Odyssey
infrared imager (LI-COR). The antibodies used in this study are de-
scribed in the Supplemental Data.
Yeast Two-Hybrid Assay
The yeast Saccharomyces cerevisiae GAL4-based two-hybrid system
was essentially as described in Freiman and Herr (1997). The GAL4-
DBD fusion expression plasmids pGBT9-HCF-1N380 (HCF-1KEL) and
pGBT9-HCFN380/P134S (HCF-1KELP134S), and GAL4-AD fusion expres-
sion plasmid pGADGH-VP16DC, have been described previously
(Freiman and Herr, 1997). The E2F proteins and mutant derivatives
were expressed as fusion proteins with GAL4-AD. dHCF Kelch domain
(amino acids 51–420, cDNA generously provided by A. Wilson) and
dE2F1 and dE2F2 (cDNAs generously provided by N. Dyson) were
expressed as fusion proteins with GAL4-DBD and GAL4-AD, respec-
tively. Protein interaction was tested by screening for growth on SD
plates without Leu, Trp, and His containing 10 mM of 3-amino-1,2,3-
triazole for 5 days at 30C in a serial 10-fold dilution spot test.
siRNA Transfections
Human HCF-1 and control siRNAs and their double serial transfection
into HeLa cells were done as described (Julien and Herr, 2003). Cells
were harvested 48 hr after the first transfection and either lysed in
SDS Laemmli buffer, subjected to RNA preparation, or fixed with form-
aldehyde for ChIP analysis. To obtain G1/S phase siRNA-treated cells,
the first thymidine block was initiated 12 hr after the first siRNA trans-
fection.
Chromatin Immunoprecipitation and Real-Time
PCR Quantification
HeLa cells were formaldehyde crosslinked, DNAs were isolated and
sonicated, and samples were immunoprecipitated, washed, and re-
verse crosslinked as described (Wells et al., 2000), except that, instead
of RSB buffer, the cells were lysed in 5 mM PIPES (pH 8.0), 85 mM KCl,
and 0.5% NP40, and the DNA was sonicated for 16 cycles of 30 s pulse
at maximum power using a Bioruptor (Diagenode). ChIP DNA was
detected by ethidium bromide staining of PCR products after gel elec-
trophoresis or by real-time PCR.
Real-time PCR of ChIP DNAs was performed in triplicate using a
SYBER green quantitative PCR kit (Applied Biosystems) and a Rotor-
gene RG300A sequence detector (Corbett Research) under conditions
standardized for each primer set described in the Supplemental Data.
PCR quantification was done with (1) the two standard curve analysis
program in Rotor-gene 6.0 software or (2) delta relative CT quantifica-
tion, in which the values are calculated relative to input as follows: delta
CT = CT (input)CT (sample); relative unit = 2delta CT. Inputs correspond
to 0.3% of total ChIP input DNA.
Quantitative Reverse-Transcriptase PCR
To assay mRNA transcript levels, total RNA was extracted with the
RNeasy system (QIAGEN), treated with DNase, and reverse tran-
scribed with ImProm II reverse transcription system (Promega). Real-
time PCR was as above and quantitated using the comparative analysis
program in Rotor-gene 6.0 software.
Supplemental Data
Supplemental Data include seven figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with thisolecular Cell 27, 107–119, July 6, 2007 ª2007 Elsevier Inc. 117
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